Intas Pharma appoints Umesh Gupta as Associate Executive Vice President - Manufacturing Operations

Published On 2025-07-29 12:00 GMT   |   Update On 2025-07-29 12:00 GMT
Advertisement

Intas Pharma has announced the appointment of Umesh Gupta as Associate Executive Vice President - Manufacturing Operations.

In a recent LinkedIn post, the company stated, "We are delighted to welcome Umesh Gupta as Associate Executive Vice President – Manufacturing Operations at Intas Pharmaceuticals."
Umesh brings with him a strong legacy of leadership in pharmaceutical manufacturing, having successfully led large-scale operational transformations across both domestic and international markets. His expertise spans end-to-end manufacturing operations, including greenfield and brownfield project execution, product lifecycle optimization, validation, and global technology transfers.
Advertisement
"With his deep industry insight and execution-driven approach, Umesh is set to play a pivotal role in strengthening our manufacturing capabilities and driving our growth ambitions forward," Intas further stated.

Sharing his enthusiasm for the new role, Gupta said, " I am excited to join Intas and contribute to building world-class manufacturing excellence through innovation, precision, and purposeful execution."

Read also: Intas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial Mandated

Prior to Intas, he served as Sr. Vice President Operations (cluster head) at Glenmark Pharma. He also held leadership roles as Vice President Operations at Granules India and has worked with several prominent pharmaceutical companies including Zydus Group, Ipca Labs, Sun Pharma, and Torrent Pharma.

Read also: Intas appoints Ex-Dr Reddy's executive Rambabu Ogirala as Associate Vice President - Manufacturing Finance

Intas is a vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Intas has set up a network of subsidiaries, under the umbrella name of Accord Healthcare to operate in global markets. Over the years, Intas has grown both organically and via acquisition, expanding its product portfolio and operations year on year. It is currently present in more than 85 countries worldwide. Intas is currently investing in a higher barrier to entry developments such as Biosimilar and New Chemical Entities.

Read also: Intas Pharma appoints Udit Sakhuja as Senior General Manager - Global New Product Launch

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News